Celgene
Celgene's Overview
Celgene Corporation was a leading American biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for cancer and immune-inflammatory diseases. Founded in 1986, Celgene was renowned for blockbuster drugs like Revlimid, Pomalyst, and Otezla. In November 2019, Celgene was acquired by Bristol Myers Squibb (BMS) in one of the largest pharmaceutical mergers, creating a combined entity with a strong portfolio in oncology, immunology, and cardiovascular disease. Celgene's legacy continues within BMS, contributing significantly to its research and product pipeline.
Where is Celgene's Headquarters?
HQ Function
Served as the global corporate headquarters, housing executive leadership, administrative functions, and significant research and development operations prior to its acquisition by Bristol Myers Squibb.
Notable Features:
Modern campus with advanced research laboratories and office facilities designed to foster collaboration and innovation.
Work Culture:
Historically known for a science-driven, patient-centric culture focused on breakthrough research and rapid development of novel therapies. Emphasized collaboration and a commitment to addressing unmet medical needs.
HQ Significance:
The Summit campus was central to Celgene's global strategy, R&D, and operational management, playing a key role in its growth into a major biopharmaceutical player before merging with BMS.
Values Reflected in HQ: The headquarters' design and functionality aimed to reflect Celgene's core values of innovation, scientific excellence, and a commitment to patients.
Location:
Prior to its acquisition by Bristol Myers Squibb in 2019, Celgene had a significant global footprint, with operations in over 50 countries. This included major research and development centers, manufacturing facilities, and commercial offices supporting the sale and distribution of its therapies worldwide, particularly in North America, Europe, and key markets in Asia. These functions are now integrated within Bristol Myers Squibb's global operations.
Street Address:
86 Morris Avenue
City:
Summit
State/Province:
New Jersey
Country:
U.S.A.
Celgene's Global Presence
Boudry, Switzerland
Address: Route de Perreux 1, 2017 Boudry, Switzerland
Key hub for ex-U.S. commercialization, market access, and coordination of clinical trials outside the United States prior to the BMS acquisition.
San Diego, California, U.S.A.
Address: Various locations; e.g., Celgene Research San Diego, 10300 Campus Point Dr area, San Diego, CA 92121 (Illustrative for the biotech hub)
Leveraged the rich biotech ecosystem in San Diego for talent acquisition and scientific collaboration, contributing significantly to Celgene's pipeline, especially in immunology.
Buying Intent Signals for Celgene
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Celgene
As of April 2025, Celgene' leadership includes:
Investors of Celgene
Celgene has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Celgene was acquired by Bristol Myers Squibb (BMS) in November 2019. As such, Celgene as an independent entity has had no executive hires or exits in the last 12 months. The most significant leadership changes occurred during the acquisition. Relevant current executive news would pertain to BMS.
Departures
New Appointments:
Technology (Tech Stack) used by Celgene
Discover the tools Celgene uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Celgene Email Formats and Examples
Prior to its acquisition by Bristol Myers Squibb in November 2019, Celgene Corporation typically used common corporate email patterns. These @celgene.com email addresses are no longer active.
[first_initial][last]@celgene.com (e.g., jsmith@celgene.com) or [first].[last]@celgene.com (e.g., john.smith@celgene.com)
Format
example.name@celgene.com
Example
0 (These email addresses are no longer active as Celgene was acquired by BMS. Emails to @celgene.com domains will likely bounce or are not monitored.)%
Success rate
News and media
Bristol Myers Squibb Press Release • November 20, 2019
Celgene Acquired by Bristol Myers Squibb, Creating a Biopharma Leader
Bristol Myers Squibb announced the completion of its acquisition of Celgene Corporation on November 20, 2019, following regulatory approvals. The merger combined Celgene's strong oncology, immunology, and inflammation portfolio with BMS's, aiming to create a leading biopharmaceutical company with a focus on innovative treatments for serious diseases....more
Business Wire (Celgene Press Release) • March 21, 2014
Celgene Historically Received FDA Approval for OTEZLA® (apremilast) for Psoriatic Arthritis
Celgene announced on March 21, 2014, that the U.S. Food and Drug Administration (FDA) approved OTEZLA® (apremilast), its oral phosphodiesterase-4 (PDE4) inhibitor, for the treatment of adult patients with active psoriatic arthritis. This marked a significant milestone for Celgene in expanding its immunology franchise. (Note: Otezla was divested to Amgen in 2019 as part of the BMS-Celgene merger conditions)....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Celgene, are just a search away.